From Discovery
to Delivery,
Biotech you
can trust
We are at the forefront of biotechnology, providing top-tier solutions in immunodiagnostics, molecular diagnostics, and nucleic acid therapies, built on proprietary biomaterials designed, developed, and optimized in-house to advance innovation in these fields.
Expertise
Oligonucleotides
Delivery
Monoclonal antibodies
Immunodiagnostics
Therapeutics
Enzymes and recombinant proteins
API
Molecular diagnostics
RAW MATERIALS
Design, development, and manufacturing of high-quality biomaterials for diagnosis and mRNA synthesis
DIAGNOSTICS
Precise, fast, and accessible in vitro diagnostic solutions to improve medical care
PHARMA
Technological platform for the design, synthesis, and delivery of mRNA and oligotherapeutics
Oligonucleotides
Monoclonal antibodies
Enzymes and recombinant proteins
RAW MATERIALS
Design, development, and manufacturing of high-quality biomaterials for diagnosis and mRNA synthesis
Immunodiagnostics
Molecular diagnostics
DIAGNOSTICS
Precise, fast, and accessible in vitro diagnostic solutions to improve medical care
Delivery
Therapeutics
API
PHARMA
Technological platform for the design, synthesis, and delivery of mRNA and oligotherapeutics
Resources and capabilities
Interdisciplinary teams
Our R&D and innovation teams are composed of highly qualified specialists with academic backgrounds in a wide range of scientific fields, including chemistry, biotechnology, biochemistry, nanotechnology, and bioinformatics. Over 40% of our R&D staff hold PhDs or bachelor's degrees.
Facilities, laboratories and equipment
Certest has over 26,000 m2 allocated to facilities and laboratories, being one of the largest areas in Europe dedicated to biotechnology. Our facilities house state-of-the art laboratories and cutting-edge equipment, empowering us to spearhead pioneering solutions for both the IVD and biopharmaceutical sectors.
Full product lifecycle
We cover the full product lifecycle, from design to commercialization. Our success is deeply rooted in our knowledge, expertise, and the ability to self-source critical raw materials, ensuring us a consistent supply and independence from third parties.
Industry 4.0
We are in a state of continuous evolution, proactively enhancing our competitiveness by embracing new technologies such as automation, digitalization, AI, bioinformatics, and data analytics. This technological transformation empowers us to streamline our processes, enabling us to respond to market demands swiftly and efficiently with a personalized touch.
Alliances and collaborations
We forge strategic partnerships with both public and private organizations to tackle new challenges and foster the generation of innovative ideas, driving the development of groundbreaking solutions.
R&D
Driven by science and creativity, we develop innovative solutions that advance global healthcare
IVDR Certification
Most of our products have the EU Quality System certificate under Regulation (EU) 2017/746
A Worldwide Company
Our distribution network reach more than 130 countries across all continents.
Sustainability
Committed to achieving the sustainable development goals (SDG) of the 2030 Agenda
